Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;43(4):949.
doi: 10.1111/liv.15551. Epub 2023 Mar 8.

Reply to the letter "Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B"

Valerie Ohlendorf  1 , Benjamin Maasoumy  1   2
Affiliations
Comment

Reply to the letter "Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B"

Valerie Ohlendorf et al. Liver Int. 2023 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Huang C-B, Su T-H, Kao J-H. Letter to the editor: anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B. Liver Int. Published online February 2, 2023. doi: 10.1111/liv.15536
    1. Ohlendorf V, Wübbolding M, Gineste P, et al. Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients. Liver Int. 2022;42(12):2674-2682. doi:10.1111/liv.15433
    1. Papatheodoridis G, Vlachogiannakos I, Cholongitas E, et al. Discontinuation of oral antivirals in chronic hepatitis B: a systematic review. Hepatology. 2016;63(5):1481-1492. doi:10.1002/hep.28438
    1. Hall SAL, Vogrin S, Wawryk O, et al. Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis. Gut. 2022;71(8):1629-1641. doi:10.1136/gutjnl-2020-323979

Substances

LinkOut - more resources